An antitumor biomedical cell product based on natural killer cells has been registered in Belarus. The technology was developed by the National Center for Pediatric Oncology, Hematology and Immunology.
On 10 January, the center hosted an off-site press conference on the topic “Cellular immunotherapy in pediatric oncology”, which was organized by the Healthcare Ministry and the National Press Center. The National Center for Pediatric Oncology, Hematology and Immunology specializes in the treatment of all malignant tumors, primary immunodeficiencies and non-malignant blood diseases in children, adolescents and young adults under 29 years of age.
In the photo: In a laboratory
